Capabilities
Our Digital Health group guides companies through the myriad considerations they encounter as the delivery of healthcare becomes increasingly digital.
As private equity investment in the Life Sciences and Healthcare industry continues to increase, our cohesive regulatory and transactional approach helps ensure success through each phase of investment.
We provide 360-degree support to companies that develop, manufacture and distribute products tailored specifically toward improving women’s health, from start-ups to global corporations.
Our Sunshine and State Law Compliance Group serves as a powerful industry advocate with respect to transparency laws for more than 100 members companies.
We established the Surprise Billing and Price Transparency Group to assist our clients in developing solutions to changes in healthcare transparency laws.
The K&S International Ad Hoc Group is a coalition of 20+ pharma and medical device companies that focuses on international transparency/disclosure laws targeting manufacturers.
November 9, 2023
General Counsel’s Internal Investigations Decision Tree for the Healthcare Industry
November 1, 2023
President Biden's Executive Order on AI - Legal Practice Snapshots
October 23, 2023
How Int'l Regulatory Collabs Can Expedite Pharma Approvals
December 1, 2023
M&A Advisor Honors King & Spalding With Healthcare/Life Sciences Deal of the Year Award
November 15, 2023
King & Spalding Once Again Receives Novartis’ “Excellence in Litigation” Award
August 1, 2023
TransMedics to Acquire Summit Aviation
May 2, 2023
Dutscher group to acquire Ozyme in France